Image 1
Chemical structure diagram of Lidocaine, showing its molecular framework with labeled functional groups and bonds.*
Lidocaine Patch
Product Images NDC 0591-3525
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lidocaine (NDC 0591-3525). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
A plasma lidocaine concentration-time curve graph showing fluctuations in plasma lidocaine levels (ng/mL) over a 72-hour period with multiple peaks and troughs, indicating repeated or sustained release doses. The x-axis represents time in hours, and the y-axis represents plasma lidocaine concentration in ng/mL.*
Image 3
Lidocaine Patch 5% packaging label from Actavis Pharma, Inc. The label indicates a topical patch dosage form containing 50 mg/g of lidocaine. The carton includes directions for use and safety instructions, specifying 30 patches, each individually boxed in envelopes. The design features prominent listing of the strength and drug name on multiple sides of the package.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
